These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19601818)

  • 1. Polymer-based drug delivery devices for neurological disorders.
    Halliday AJ; Cook MJ
    CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):205-21. PubMed ID: 19601818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders.
    Ong WY; Shalini SM; Costantino L
    Curr Med Chem; 2014; 21(37):4247-56. PubMed ID: 25039773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review About the Drug Delivery from Microsponges.
    Junqueira MV; Bruschi ML
    AAPS PharmSciTech; 2018 May; 19(4):1501-1511. PubMed ID: 29484616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery systems for small molecule drugs, proteins, and DNA: the neuroscience/biomaterial interface.
    Whittlesey KJ; Shea LD
    Exp Neurol; 2004 Nov; 190(1):1-16. PubMed ID: 15473976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview on Therapeutic Applications of Microparticulate Drug Delivery Systems.
    Bale S; Khurana A; Reddy AS; Singh M; Godugu C
    Crit Rev Ther Drug Carrier Syst; 2016; 33(4):309-361. PubMed ID: 27910739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
    Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
    Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal.
    Kanwar JR; Sun X; Punj V; Sriramoju B; Mohan RR; Zhou SF; Chauhan A; Kanwar RK
    Nanomedicine; 2012 May; 8(4):399-414. PubMed ID: 21889479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal delivery: circumventing the iron curtain to treat neurological disorders.
    Jiang Y; Li Y; Liu X
    Expert Opin Drug Deliv; 2015; 12(11):1717-25. PubMed ID: 26206202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles.
    Patel M; Souto EB; Singh KK
    Expert Opin Drug Deliv; 2013 Jul; 10(7):889-905. PubMed ID: 23550609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in recombinant polymers for delivery of bioactive agents.
    Ghandehari H; Hatefi A
    Adv Drug Deliv Rev; 2010 Dec; 62(15):1403. PubMed ID: 20667495
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug delivery systems from nose to brain.
    Misra A; Kher G
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
    Nair KGS; Ramaiyan V; Sukumaran SK
    Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolving microneedles for transdermal drug delivery: Advances and challenges.
    Ita K
    Biomed Pharmacother; 2017 Sep; 93():1116-1127. PubMed ID: 28738520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodrug approaches to reduce hyperexcitation in the CNS.
    Vytla D; Combs-Bachmann RE; Hussey AM; McCarron ST; McCarthy DS; Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):666-85. PubMed ID: 22138074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecularly imprinted polymer essentials: curation of anticancer, ophthalmic, and projected gene therapy drug delivery systems.
    Tuwahatu CA; Yeung CC; Lam YW; Roy VAL
    J Control Release; 2018 Oct; 287():24-34. PubMed ID: 30110614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymersome-based drug-delivery strategies for cancer therapeutics.
    Anajafi T; Mallik S
    Ther Deliv; 2015; 6(4):521-34. PubMed ID: 25996048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours.
    Raza SM; Pradilla G; Legnani FG; Thai QA; Olivi A; Weingart JD; Brem H
    Expert Opin Biol Ther; 2005 Apr; 5(4):477-94. PubMed ID: 15934827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.